CENTER OVERVIEW ? ABSTRACT For 30 years, the Diabetes Research Center (DRC) of the Joslin Diabetes Center, with its core laboratories including the Boston University-Joslin Regional Computational core (BUJRC), Enrichment Program, and Pilot and Feasibility (P&F) program, has synergized the collaborative expansion of basic and clinical diabetes research at Joslin, Harvard Medical School (HMS) and the neighboring research institutions. During the last 5 years, the Joslin Research Division generated paradigm-changing breakthroughs on the understanding of the pathogenesis of various forms of diabetes and its complications. The success in making these discoveries has been closely linked to the continuously evolving technologies and computational biology services provided by the Joslin DRC. In addition, Joslin made significant renovations to many of its clinical and research laboratories. This application summarizes the progress and innovations that have been made to the various components of the Joslin DRC over this grant period. The Animal Physiology Core and Flow Cytometry Core will have exciting new capabilities with the building of a germ-free mouse facility and the acquisition of new cell sorting and imaging instruments. The Advanced Genomic and Genetics Core will become the Molecular Phenotyping and Genotyping Core, allowing the incorporation of bioenergetics and new DNA chip capabilities. The iPS Cell Core will be Genome Editing Core, introducing CRISPR-Cas9 technology for cell-based and rodent model studies. The BUJRC Bioinformatics Core, due to significant increase in demand, will be enlarged to add new services. The DRC is also proposing a new Clinical Translational Research Center Core (CTRC), which will complement our renovated and enlarged Clinical Research Center facility that is funded by Joslin. The CTRC is being proposed due to the significant increase in our translational and clinical research studies, which now account for 50% of Joslin's research efforts. This new Core will coordinate and synergize the large number of clinical/translational studies now on-going at Joslin and enhance their capabilities by improving clinical design, specific procedures for metabolic studies, identification of special diabetic populations and cohorts, and facilitating sources and resources for biological samples and repositories. The previously DRC-supported Advanced Microscopy Core, the Animal Facilities, Specialized Assay Core, Media Core and the Clinical Research Center will continue with support by Joslin. The P&F program has been very successful in supporting early investigators, thus identifying innovative research at Joslin, Harvard and Boston institutions. More than half of P+F Program awardees have subsequently competed successfully for NIH support. The Enrichment Program is the largest diabetes and metabolic disease educational program for post-doctoral fellows, students and investigators in the Harvard Medical School area, and is jointly supported by the DRC and Joslin funding. Joslin hosts a large international symposium every three years. Thus, the role of the DRC has been clearly important to this community of investigators and will continue to be pivotal in the proposed grant period.

Public Health Relevance

For the last 30 years, the Joslin DRC has catalyzed the diabetes research effort at Joslin, Harvard and Boston research institutions. The contributions of its Cores, Pilot and Feasibility Program, and Enrichment Program can be measured by their heavy use involving over 30 laboratories at Joslin, and 40 other laboratories within the Boston and Massachusetts area. The product has been groundbreaking research that has generated many new ideas regarding the pathogenesis of diabetes and its complications. The results have also translated into clinical research and treatments, including FDA-approved therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK036836-31
Application #
9318909
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Hyde, James F
Project Start
1997-02-15
Project End
2022-03-31
Budget Start
2017-07-01
Budget End
2018-03-31
Support Year
31
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Rezanejad, Habib; Ouziel-Yahalom, Limor; Keyzer, Charlotte A et al. (2018) Heterogeneity of SOX9 and HNF1? in Pancreatic Ducts Is Dynamic. Stem Cell Reports 10:725-738
Katz, Michelle L; Guo, Zijing; Cheema, Alina et al. (2018) Management of Cardiovascular Disease Risk in Teens with Type 1 Diabetes: Perspectives of Teens With and Without Dyslipidemia and Parents. Pediatr Diabetes :
Gordin, Daniel; Harjutsalo, Valma; Tinsley, Liane et al. (2018) Differential Association of Microvascular Attributions With Cardiovascular Disease in Patients With Long Duration of Type 1 Diabetes. Diabetes Care 41:815-822
Teló, G H; Dougher, C E; Volkening, L K et al. (2018) Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes. Diabet Med 35:1355-1363
Srinivasan, Shylaja; Kaur, Varinderpal; Chamarthi, Bindu et al. (2018) TCF7L2 Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH). Diabetes Care 41:554-561
Goldford, Joshua E; Lu, Nanxi; Baji?, Djordje et al. (2018) Emergent simplicity in microbial community assembly. Science 361:469-474
Soto, Marion; Orliaguet, Lucie; Reyzer, Michelle L et al. (2018) Pyruvate induces torpor in obese mice. Proc Natl Acad Sci U S A 115:810-815
Karst, Sonja G; Lammer, Jan; Radwan, Salma H et al. (2018) Characterization of In Vivo Retinal Lesions of Diabetic Retinopathy Using Adaptive Optics Scanning Laser Ophthalmoscopy. Int J Endocrinol 2018:7492946
Espeland, Mark A; Carmichael, Owen; Hayden, Kathleen et al. (2018) Long-term Impact of Weight Loss Intervention on Changes in Cognitive Function: Exploratory Analyses from the Action for Health in Diabetes Randomized Controlled Clinical Trial. J Gerontol A Biol Sci Med Sci 73:484-491
Kim, Youngjo; Bayona, Princess Wendy; Kim, Miri et al. (2018) Macrophage Lamin A/C Regulates Inflammation and the Development of Obesity-Induced Insulin Resistance. Front Immunol 9:696

Showing the most recent 10 out of 1120 publications